De novo DDX3X variants account for 1–3% of unexplained intellectual disability (ID) or developmental delay (DD) (Deciphering Developmental Disorders Study., 2017; Maulik et al., 2011) and also perform as a highly plausible pathogenic gene for childhood apraxia of speech (CAS) (Hildebrand et al., 2020). The gene discussed is DDX3X; the disease is Global developmental delay.